VFA
EIDX

Valeo Financial Advisors’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Valeo Financial Advisors’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-60
Closed -$8K – 2266
2020
Q4 		$8K Hold
60
– – ﹤0.01% 1267
2020
Q3 		$3K Hold
60
– – ﹤0.01% 1375
2020
Q2 		$3K Hold
60
– – ﹤0.01% 1709
2020
Q1 		$3K Sell
60
-2
-3% -$102 ﹤0.01% 1471
2019
Q4 		$4K Buy
+62
New +$3.07K ﹤0.01% 1365

Valeo Financial Advisors's EIDX Position: Q1 2021 in Review

Valeo Financial Advisors sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 60 shares — an estimated $8K sold.

Valeo Financial Advisors first reported a position in EIDX in Q4 2019 and held it in 5 quarters. The position peaked at $8K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

  • Valeo Financial Advisors reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 60 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $8K.
  • Valeo Financial Advisors first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Valeo Financial Advisors's Eidos Therapeutics, Inc. Common Stock position peaked at $8K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Valeo Financial Advisors's 13F filing for Q1 2021, filed 12 Apr 2021.